APA (7th ed.) Citation

Yokote, K., Yamashita, S., Arai, H., Araki, E., Matsushita, M., Nojima, T., . . . Ishibashi, S. (2021). Effects of pemafibrate on glucose metabolism markers and liver function tests in patients with hypertriglyceridemia: A pooled analysis of six phase 2 and phase 3 randomized double‐blind placebo‐controlled clinical trials. BMC.

Chicago Style (17th ed.) Citation

Yokote, Koutaro, Shizuya Yamashita, Hidenori Arai, Eiichi Araki, Mitsunori Matsushita, Toshiaki Nojima, Hideki Suganami, and Shun Ishibashi. Effects of Pemafibrate on Glucose Metabolism Markers and Liver Function Tests in Patients with Hypertriglyceridemia: A Pooled Analysis of Six Phase 2 and Phase 3 Randomized Double‐blind Placebo‐controlled Clinical Trials. BMC, 2021.

MLA (8th ed.) Citation

Yokote, Koutaro, et al. Effects of Pemafibrate on Glucose Metabolism Markers and Liver Function Tests in Patients with Hypertriglyceridemia: A Pooled Analysis of Six Phase 2 and Phase 3 Randomized Double‐blind Placebo‐controlled Clinical Trials. BMC, 2021.